We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Infectious Diseases

Long COVID and the Workforce: Navigating a Complex Path Back to Employment

MedXY Editorial Team•Oct 1, 2025•Infectious Diseases
chronic illnesslong COVIDoccupational health

Highlights

  • Long COVID affects an estimated 16 million U.S. workers, with many unable to return to work due to persistent symptoms and administrative hurdles.
  • Workers face challenges in proving occupational acquisition of COVID-19, hampering access to workers’ compensation benefits.
  • A lack of standardized diagnostics and FDA-approved treatments complicates insurance coverage and prolongs recovery.
  • Older workers and retirees are disproportionately affected, with substantial personal and system-wide economic impacts.

Background and Disease Burden

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Long COVID in Pregnancy: Assessing Risks for Preterm Birth and Hypertensive DisordersThis study evaluates the impact of Long COVID on pregnancy outcomes, finding no significant risk for preterm birth but a potential association with hypertensive disorders, underscoring the need for further research.Aug 31, 2026Decoding Systemic Inflammation in Long COVID and Autoimmune Diseases: The Role of Intestinal Flagellin and the TLR5-IL-15-ARA AxisThis article explores how intestinal flagellin drives systemic inflammation via the TLR5-IL-15-ARA pathway in long COVID, rheumatoid arthritis, ankylosing spondylitis, and IBD, highlighting potential therapeutic targets and biomarkers.Aug 22, 2026Unraveling the Gut-Lung Axis: Intestinal Flagellin as a Driver of Multisystem Inflammation via the TLR5-IL-15-ARA PathwayFlagellated gut bacteria activate TLR5 on neutrophils, triggering IL-15 release and macrophage arachidonic acid production, driving systemic inflammation in long COVID, rheumatoid arthritis, ankylosing spondylitis, and IBD.Aug 21, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Fluvoxamine Shows Promise for Treating Long COVID Fatigue: Results from Adaptive Randomized Trial
A randomized trial of 399 adults with long COVID fatigue found that fluvoxamine significantly reduced fatigue severity at 60 and 90 days compared to placebo, while metformin showed no benefit. The study represents a potential breakthrough i
Apr 3, 2026
The Human Cost of Respiratory Care: Why Multidisciplinary Teams Cannot Shield Physicians from BurnoutA comprehensive study of 569 cystic fibrosis professionals identifies physicians as the group most vulnerable to burnout, emotional exhaustion, and depersonalization. The research highlights administrative burden as a primary driver and calMar 19, 2026
Metformin and Ursodeoxycholic Acid Fail to Improve Post-COVID Recovery: Insights from a Randomized Controlled TrialA randomized clinical trial indicates that neither metformin nor ursodeoxycholic acid (UDCA) significantly improves recovery from postacute sequelae of SARS-CoV-2 (PASC) compared to placebo, highlighting the ongoing challenge of finding effMar 13, 2026